Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: Polyplexes vs micelleplexes

Dana J. Gary, Hoyoung Lee, Rahul Sharma, Jae Sung Lee, Youngwook Kim, Zheng Yun Cui, Di Jia, Valorie D. Bowman, Paul R. Chipman, Lei Wan, Yi Zou, Guangzhao Mao, Keunchil Park, Brittney-Shea Herbert, Stephen F. Konieczny, You Yeon Won

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Micelle-based siRNA carriers ("micelleplexes") were prepared from the A-B-C triblock copolymer polyethylene glycol)-poly(n-butyl acrylate)-poly(2-(dimethylamino)ethyl methacrylate) (PEG-PnBA-PDMAEMA), and their in vitro performance and in vivo biodistribution properties were compared with the benchmark PEGylated and basic polycation systems PEG-PDMAEMA and PDMAEMA, respectively. The micelle architecture, incorporating increased PEG shielding and a larger particle size (∼50 nm) than polycation-based complexes (polyplexes; ∼10 nm), enhances siRNA delivery performance in two important aspects: in vitro gene silencing efficiency and in vivo tumor accumulation. The in vitro gene silencing efficiency of the micelleplexes (24% in HeLa cells) was significantly better than the statistically insignificant levels observed for PDMAEMA and PEG-PDMAEMA polyplexes under identical conditions. This enhancement is linked to the different mechanisms by which micelleplexes are internalized (i.e., caveolar, etc.) compared to PDMAEMA and PEG-PDMAEMA polyplexes. Folate-functionalization significantly improved micelleplex uptake but had negligible influence on gene-silencing efficiency, suggesting that this parameter is not limited by cellular internalization. In vivo biodistribution analysis revealed that siRNA delivered by micelleplexes was more effectively accumulated and retained in tumor tissues than that delivered by PEGylated polyplexes. Overall, the micelle particle size and architecture appear to improve in vitro and in vivo delivery characteristics without significantly changing other properties, such as cytotoxicity and resistance to enzymes and dissociation. The self-assembled nature of micelleplexes is expected to enable incorporation of imaging modalities inside the hydrophobic micelle core, thus combining therapeutic and diagnostic capabilities. The findings from the present study suggest that the micelleplex-type carrier architecture is a useful platform for potential theranostic and tumor-targeting applications.

Original languageEnglish
Pages (from-to)3493-3505
Number of pages13
JournalACS Nano
Volume5
Issue number5
DOIs
StatePublished - May 24 2011

Fingerprint

Small Interfering RNA
Polyethylene glycols
delivery
micelles
Micelles
genes
tumors
Tumors
Genes
Particle size
acrylates
shielding
enzymes
glycols
polyethylenes
Cytotoxicity
copolymers
platforms
Shielding
Block copolymers

Keywords

  • In vitro performance
  • In vivo biodistribution
  • Micelleplex
  • Nanocarrier
  • Polyplex
  • siRNA delivery

ASJC Scopus subject areas

  • Engineering(all)
  • Materials Science(all)
  • Physics and Astronomy(all)

Cite this

Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution : Polyplexes vs micelleplexes. / Gary, Dana J.; Lee, Hoyoung; Sharma, Rahul; Lee, Jae Sung; Kim, Youngwook; Cui, Zheng Yun; Jia, Di; Bowman, Valorie D.; Chipman, Paul R.; Wan, Lei; Zou, Yi; Mao, Guangzhao; Park, Keunchil; Herbert, Brittney-Shea; Konieczny, Stephen F.; Won, You Yeon.

In: ACS Nano, Vol. 5, No. 5, 24.05.2011, p. 3493-3505.

Research output: Contribution to journalArticle

Gary, DJ, Lee, H, Sharma, R, Lee, JS, Kim, Y, Cui, ZY, Jia, D, Bowman, VD, Chipman, PR, Wan, L, Zou, Y, Mao, G, Park, K, Herbert, B-S, Konieczny, SF & Won, YY 2011, 'Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: Polyplexes vs micelleplexes', ACS Nano, vol. 5, no. 5, pp. 3493-3505. https://doi.org/10.1021/nn102540y
Gary, Dana J. ; Lee, Hoyoung ; Sharma, Rahul ; Lee, Jae Sung ; Kim, Youngwook ; Cui, Zheng Yun ; Jia, Di ; Bowman, Valorie D. ; Chipman, Paul R. ; Wan, Lei ; Zou, Yi ; Mao, Guangzhao ; Park, Keunchil ; Herbert, Brittney-Shea ; Konieczny, Stephen F. ; Won, You Yeon. / Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution : Polyplexes vs micelleplexes. In: ACS Nano. 2011 ; Vol. 5, No. 5. pp. 3493-3505.
@article{79328baf4e9f4a4087376ddddd7fcaef,
title = "Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: Polyplexes vs micelleplexes",
abstract = "Micelle-based siRNA carriers ({"}micelleplexes{"}) were prepared from the A-B-C triblock copolymer polyethylene glycol)-poly(n-butyl acrylate)-poly(2-(dimethylamino)ethyl methacrylate) (PEG-PnBA-PDMAEMA), and their in vitro performance and in vivo biodistribution properties were compared with the benchmark PEGylated and basic polycation systems PEG-PDMAEMA and PDMAEMA, respectively. The micelle architecture, incorporating increased PEG shielding and a larger particle size (∼50 nm) than polycation-based complexes (polyplexes; ∼10 nm), enhances siRNA delivery performance in two important aspects: in vitro gene silencing efficiency and in vivo tumor accumulation. The in vitro gene silencing efficiency of the micelleplexes (24{\%} in HeLa cells) was significantly better than the statistically insignificant levels observed for PDMAEMA and PEG-PDMAEMA polyplexes under identical conditions. This enhancement is linked to the different mechanisms by which micelleplexes are internalized (i.e., caveolar, etc.) compared to PDMAEMA and PEG-PDMAEMA polyplexes. Folate-functionalization significantly improved micelleplex uptake but had negligible influence on gene-silencing efficiency, suggesting that this parameter is not limited by cellular internalization. In vivo biodistribution analysis revealed that siRNA delivered by micelleplexes was more effectively accumulated and retained in tumor tissues than that delivered by PEGylated polyplexes. Overall, the micelle particle size and architecture appear to improve in vitro and in vivo delivery characteristics without significantly changing other properties, such as cytotoxicity and resistance to enzymes and dissociation. The self-assembled nature of micelleplexes is expected to enable incorporation of imaging modalities inside the hydrophobic micelle core, thus combining therapeutic and diagnostic capabilities. The findings from the present study suggest that the micelleplex-type carrier architecture is a useful platform for potential theranostic and tumor-targeting applications.",
keywords = "In vitro performance, In vivo biodistribution, Micelleplex, Nanocarrier, Polyplex, siRNA delivery",
author = "Gary, {Dana J.} and Hoyoung Lee and Rahul Sharma and Lee, {Jae Sung} and Youngwook Kim and Cui, {Zheng Yun} and Di Jia and Bowman, {Valorie D.} and Chipman, {Paul R.} and Lei Wan and Yi Zou and Guangzhao Mao and Keunchil Park and Brittney-Shea Herbert and Konieczny, {Stephen F.} and Won, {You Yeon}",
year = "2011",
month = "5",
day = "24",
doi = "10.1021/nn102540y",
language = "English",
volume = "5",
pages = "3493--3505",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution

T2 - Polyplexes vs micelleplexes

AU - Gary, Dana J.

AU - Lee, Hoyoung

AU - Sharma, Rahul

AU - Lee, Jae Sung

AU - Kim, Youngwook

AU - Cui, Zheng Yun

AU - Jia, Di

AU - Bowman, Valorie D.

AU - Chipman, Paul R.

AU - Wan, Lei

AU - Zou, Yi

AU - Mao, Guangzhao

AU - Park, Keunchil

AU - Herbert, Brittney-Shea

AU - Konieczny, Stephen F.

AU - Won, You Yeon

PY - 2011/5/24

Y1 - 2011/5/24

N2 - Micelle-based siRNA carriers ("micelleplexes") were prepared from the A-B-C triblock copolymer polyethylene glycol)-poly(n-butyl acrylate)-poly(2-(dimethylamino)ethyl methacrylate) (PEG-PnBA-PDMAEMA), and their in vitro performance and in vivo biodistribution properties were compared with the benchmark PEGylated and basic polycation systems PEG-PDMAEMA and PDMAEMA, respectively. The micelle architecture, incorporating increased PEG shielding and a larger particle size (∼50 nm) than polycation-based complexes (polyplexes; ∼10 nm), enhances siRNA delivery performance in two important aspects: in vitro gene silencing efficiency and in vivo tumor accumulation. The in vitro gene silencing efficiency of the micelleplexes (24% in HeLa cells) was significantly better than the statistically insignificant levels observed for PDMAEMA and PEG-PDMAEMA polyplexes under identical conditions. This enhancement is linked to the different mechanisms by which micelleplexes are internalized (i.e., caveolar, etc.) compared to PDMAEMA and PEG-PDMAEMA polyplexes. Folate-functionalization significantly improved micelleplex uptake but had negligible influence on gene-silencing efficiency, suggesting that this parameter is not limited by cellular internalization. In vivo biodistribution analysis revealed that siRNA delivered by micelleplexes was more effectively accumulated and retained in tumor tissues than that delivered by PEGylated polyplexes. Overall, the micelle particle size and architecture appear to improve in vitro and in vivo delivery characteristics without significantly changing other properties, such as cytotoxicity and resistance to enzymes and dissociation. The self-assembled nature of micelleplexes is expected to enable incorporation of imaging modalities inside the hydrophobic micelle core, thus combining therapeutic and diagnostic capabilities. The findings from the present study suggest that the micelleplex-type carrier architecture is a useful platform for potential theranostic and tumor-targeting applications.

AB - Micelle-based siRNA carriers ("micelleplexes") were prepared from the A-B-C triblock copolymer polyethylene glycol)-poly(n-butyl acrylate)-poly(2-(dimethylamino)ethyl methacrylate) (PEG-PnBA-PDMAEMA), and their in vitro performance and in vivo biodistribution properties were compared with the benchmark PEGylated and basic polycation systems PEG-PDMAEMA and PDMAEMA, respectively. The micelle architecture, incorporating increased PEG shielding and a larger particle size (∼50 nm) than polycation-based complexes (polyplexes; ∼10 nm), enhances siRNA delivery performance in two important aspects: in vitro gene silencing efficiency and in vivo tumor accumulation. The in vitro gene silencing efficiency of the micelleplexes (24% in HeLa cells) was significantly better than the statistically insignificant levels observed for PDMAEMA and PEG-PDMAEMA polyplexes under identical conditions. This enhancement is linked to the different mechanisms by which micelleplexes are internalized (i.e., caveolar, etc.) compared to PDMAEMA and PEG-PDMAEMA polyplexes. Folate-functionalization significantly improved micelleplex uptake but had negligible influence on gene-silencing efficiency, suggesting that this parameter is not limited by cellular internalization. In vivo biodistribution analysis revealed that siRNA delivered by micelleplexes was more effectively accumulated and retained in tumor tissues than that delivered by PEGylated polyplexes. Overall, the micelle particle size and architecture appear to improve in vitro and in vivo delivery characteristics without significantly changing other properties, such as cytotoxicity and resistance to enzymes and dissociation. The self-assembled nature of micelleplexes is expected to enable incorporation of imaging modalities inside the hydrophobic micelle core, thus combining therapeutic and diagnostic capabilities. The findings from the present study suggest that the micelleplex-type carrier architecture is a useful platform for potential theranostic and tumor-targeting applications.

KW - In vitro performance

KW - In vivo biodistribution

KW - Micelleplex

KW - Nanocarrier

KW - Polyplex

KW - siRNA delivery

UR - http://www.scopus.com/inward/record.url?scp=80051512877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051512877&partnerID=8YFLogxK

U2 - 10.1021/nn102540y

DO - 10.1021/nn102540y

M3 - Article

C2 - 21456626

AN - SCOPUS:80051512877

VL - 5

SP - 3493

EP - 3505

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 5

ER -